On July 11, a prominent PEGUS Research sponsor submitted its application to the FDA for a first-ever over-the-counter (OTC) oral contraceptive in the US. PEGUS…
John EvansJuly 14, 2022
Latest News
Results from a US Real-World Evidence (RWE) study conducted by PEGUS were recently published in Contraception, an international reproductive health journal and the official journal…
John EvansJune 14, 2022
The Sterling Institutional Review Board (IRB) featured PEGUS Research’s innovative and versatile marketing strategies in their latest Whitepaper article titled “PPC and Social Media Patient…
John EvansApril 12, 2022
On 16 August, 2021, the UK Medicine and Healthcare products Regulatory Agency (MHRA) made Nuromol, a medicine that contains 200mg of ibuprofen and 500mg of…
John EvansAugust 20, 2021
On 17 June 2021, the US Food and Drug Administration (FDA) announced approval of a new nasal antihistamine (Astepro Allergy and Children’s Astepro Allergy) for…
John EvansJune 21, 2021
Clark Richardson, PEGUS President & CEO, participated in a 09 June 2021 FDA public workshop titled, “The Nonprescription Drug Facts Label in a Changing Consumer…
John EvansJune 14, 2021
Innovating at Unprecedented Pace COVID-19 prompted dramatic changes in the way we conduct research. In the months since the pandemic began, we have completed literally…
John EvansFebruary 8, 2021
Learn more about PEGUS
Our Pharmaceutical Research Services
Learn More
Join our Pharmacy Network.
Are you a registered pharmacist interested in joining our network?
Learn More
